Objective: Compare adult migraineurs' health related quality of life t
o adults in the general U.S. Population reporting no chronic condition
s, and to samples of patients with other chronic conditions. Methods:
Subjects (n=845) were surveyed 2-6 months after participation in a pla
cebo-controlled clinical trial and asked to complete a questionnaire i
ncluding the SF-36 Health Survey, a migraine severity measurement scal
e and demographics. Results were adjusted for severity of illness and
comorbidities. Scores were compared with responses to the same survey
by the U.S. sample and by patients with other chronic conditions. Resu
lts: Response rate was 67%. After adjustment for comorbid conditions,
SF-36 scale scores were significantly (P 0.001) lower in migraineurs,
relative to age and sex-adjusted norms for the U.S. sample with no chr
onic conditions. Some health dimensions were more affected by migraine
than other chronic conditions, while other dimensions were less affec
ted by migraine. Measures of bodily pain, role disability due to physi
cal health and social functioning discriminated best between migraineu
rs, the U.S. sample, and patients with other chronic conditions. Patie
nts reporting moderate, severe and very severe migraines scored signif
icantly (P less-than-or-equal-to 0.001) lower on five of the eight SF-
36 scales than the U.S. sample. Conclusions: Migraine has a unique, si
gnificant quality of life burden.